August Newsletter Now Available! In our August Newsletter, we highlight several exciting new releases! Nasal Glucagon has been approved, generic Dapagliflozin has been released, and Cleveland Clinic has synthesized a … Continue reading August Newsletter | Diabetes Medications Approved & Supplements Reviewed
The marketing application for a generic version of Farxiga, or dapagliflozin has received tentative approval from the US Food and Drug Administration (USFDA). Alembic Pharmaceuticals received a nod for its … Continue reading Dapagliflozin biosimilar gets tentative FDA approval
New studies show that sitting for too long can impair health and even shorten life expectancy. It’s difficult to keep active in a world of screens, movie theaters, and desk … Continue reading 5 Steps to Stop Sitting and Increase Longevity
Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday … Continue reading Question of the Week | August 6, 2019
While most know there are great benefits to getting out in nature, Medical News Today has released a study showing that simply viewing nature can reduce cravings such as smoking, … Continue reading Getting Back to Basics: How Green is Good
Based on a study published in Diabetes Care in April 2019, it appears that there is a positive association between use of topical corticosteroids and new incident diabetes. A Danish … Continue reading Do topical steroids increase risk of type 2 diabetes?
A recent study conducted by the Aarhus University Hospital in Denmark found that three out of every four persons living with obesity and type 2 diabetes who receive a RYGB … Continue reading Gastric Bypass Surgery associated with high type 2 diabetes remission rates
Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday … Continue reading Question of the Week | July 30, 2019